TRADE NEWS: Agilent Technologies Introduces OneSeq to Streamline Cytogenetic Research
25 Febrero 2015 - 10:00AM
Business Wire
Assay Allows Scientists to Identify
Mutations and Copy Number Changes in a Single Reaction
Agilent Technologies Inc. (NYSE:A) today introduced OneSeq, the
industry’s first all-in-one target enrichment product for
next-generation sequencing. OneSeq is designed to detect and
analyze copy number variations, loss of heterozygosity, and
mutations in a single reaction for use in constitutional disease
research.
Agilent is showcasing the new product at the annual Advances in
Genome Biology and Technology (AGBT) conference in Marco Island,
Florida, this week.
Powered by Agilent’s industry-leading SureSelect
target-enrichment platform, the new OneSeq constitutional research
panel will help laboratories involved in cytogenetic research save
time gathering and analyzing complex, multifactorial data.
“OneSeq enables researchers to study both disease-associated
targets and copy number variants at the same time,” said Alessandro
Borsatti, a senior director of marketing at Agilent. “The
all-in-one NGS assay—another industry first from the pioneers of
target enrichment—provides more information than single molecular
techniques, allowing scientists to streamline their workflow.”
Borsatti noted that researchers can easily combine OneSeq with
Agilent’s free-of-charge SureCall software to integrate data
analysis of copy number variations, single nucleotide
polymorphisms, indels, and loss of heterozygosity.
“This combination offers the most cost-effective and streamlined
method of studying multiple DNA changes associated with genetic
disorders,” Borsatti said. “Whole genome sequencing and its
associated data analysis are far more laborious and costly.”
In addition, Agilent’s online design application, SureDesign,
enables researchers to customize OneSeq by adding any gene panel of
interest to the CNV backbone to suit their needs.
About Agilent Technologies
Agilent Technologies Inc. (NYSE:A), a global leader in life
sciences, diagnostics and applied chemical markets, is the premier
laboratory partner for a better world. Agilent works with customers
in more than 100 countries, providing instruments, software,
services and consumables for the entire laboratory workflow.
Agilent generated revenues of $4.0 billion in fiscal 2014. The
company employs about 12,000 people worldwide. Information about
Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and
executive news is available at www.agilent.com/go/news.
for Agilent Technologies Inc.Jennifer Mann, +1
303-357-2391jmann@webershandwick.com
American Oil & Gas Common Stock (NYSE:AEZ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
American Oil & Gas Common Stock (NYSE:AEZ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024